Mark A. Deeg
Impact in
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
Papers in
-
- Diabetes Treatment and Management 12
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
-
- Lipid metabolism and biosynthesis 9
- Co-authors
- David W. Crabb (3 shared papers)Naga Chalasani (4 shared papers)Min You (1 shared paper)Monika Fischer (1 shared paper)Haoda Fu (4 shared papers)Meng Hee Tan (4 shared papers)David E. Moller (3 shared papers)Ronald B Goldberg (3 shared papers)
- Journals
- Diabetes Care (7 papers)Metabolism (4 papers)Biochemical Journal (3 papers)Osteoarthritis and Cartilage (3 papers)Journal of Biological Chemistry (3 papers)
- Partner nations
- United StatesUnited KingdomNigeria
In The Last Decade
Mark A. Deeg
82 papers receiving 4.3k citations
Mark A. Deeg's Hit Papers
Peers
Comparison fields: 5 of 103
- Endocrinology, Diabetes and Metabolism 981
- Epidemiology 755
- Pathology and Forensic Medicine 338
- Molecular Biology 1.3k
- Biochemistry 124
Countries citing papers authored by Mark A. Deeg
This map shows the geographic impact of Mark A. Deeg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Deeg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Deeg more than expected).
Fields of papers citing papers by Mark A. Deeg
This network shows the impact of papers produced by Mark A. Deeg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Deeg. The network helps show where Mark A. Deeg may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Deeg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes Hit paper breakdown → | 2013 | 792 |
| 2 | A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia Hit paper breakdown → | 2005 | 679 |
| 3 | 2002 | 483 | |
| 4 | 2004 | 300 | |
| 5 | 2015 | 178 | |
| 6 | 2007 | 159 | |
| 7 | 2006 | 107 | |
| 8 | 2015 | 101 | |
| 9 | 1992 | 91 | |
| 10 | 2000 | 68 | |
| 11 | 2007 | 65 | |
| 12 | 2016 | 58 | |
| 13 | 2016 | 58 | |
| 14 | 2003 | 57 | |
| 15 | 2004 | 52 | |
| 16 | 1999 | 51 | |
| 17 | 2006 | 48 | |
| 18 | 2015 | 47 | |
| 19 | 2008 | 43 | |
| 20 | 1997 | 41 |
About Mark A. Deeg
Mark A. Deeg is a scholar working on Endocrinology, Diabetes and Metabolism, Biochemistry, Surgery, Molecular Biology and Nephrology, having authored 82 papers that have together received 4.5k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (12 papers), Lipoproteins and Cardiovascular Health (9 papers), Lipid metabolism and biosynthesis (9 papers), Pancreatic function and diabetes (8 papers), Cholesterol and Lipid Metabolism (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Glycosylation and Glycoproteins Research (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (981 citations), Epidemiology (755 citations), Pathology and Forensic Medicine (338 citations), Molecular Biology (1.3k citations) and Biochemistry (124 citations). Mark A. Deeg has collaborated with scholars based in United States, United Kingdom and Nigeria. Frequent co-authors include David W. Crabb, Naga Chalasani, Min You, Monika Fischer, Haoda Fu, Meng Hee Tan, David E. Moller, Ronald B Goldberg, John B. Buse and David M. Kendall. Their work appears in journals such as Diabetes Care, Metabolism, Biochemical Journal, Osteoarthritis and Cartilage and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.